Monopar Therapeutics (MNPR) Other Non-Current Assets: 2016-2020
Historic Other Non-Current Assets for Monopar Therapeutics (MNPR) over the last 2 years, with Sep 2020 value amounting to $68,858.
- Monopar Therapeutics' Other Non-Current Assets was N/A to $68,858 in Q3 2020 from the same period last year, while for Sep 2020 it was $68,858, marking a year-over-year change of. This contributed to the annual value of $122,381 for FY2019, which is 86.18% up from last year.
- According to the latest figures from Q3 2020, Monopar Therapeutics' Other Non-Current Assets is $68,858, which was down 5.74% from $73,050 recorded in Q2 2020.
- In the past 5 years, Monopar Therapeutics' Other Non-Current Assets registered a high of $800,393 during Q4 2016, and its lowest value of $65,731 during Q4 2018.
- For the 3-year period, Monopar Therapeutics' Other Non-Current Assets averaged around $293,209, with its median value being $122,381 (2020).
- Its Other Non-Current Assets has fluctuated over the past 5 years, first crashed by 91.78% in 2018, then soared by 86.18% in 2019.
- Monopar Therapeutics' Other Non-Current Assets (Quarterly) stood at $800,393 in 2016, then dropped by 0.05% to $800,031 in 2017, then plummeted by 91.78% to $65,731 in 2018, then soared by 86.18% to $122,381 in 2019, then reached $68,858 in 2020.
- Its Other Non-Current Assets was $68,858 in Q3 2020, compared to $73,050 in Q2 2020 and $122,381 in Q1 2020.